Status:
COMPLETED
Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
The Affiliated Hospital Of Southwest Medical University
Conditions:
Lung Neoplasm Malignant
Eligibility:
All Genders
Phase:
NA
Brief Summary
A small-scale pilot randomized controlled trial conducted by the investigators demonstrated some preliminary evidence that inspiratory muscle training (IMT) could be a promising self-management method...
Detailed Description
The hypothesis of this study is that inspiratory muscle training (IMT) for a three-month treatment will improve dyspnea in lung cancer patients with stable disease experiencing breathlessness. Plan o...
Eligibility Criteria
Inclusion
- adults with histological diagnosis of primary LC or mesothelioma;
- refractory dyspnea not responding to current treatment for the past 2 weeks;
- expected prognosis of \>3 months as judged by the clinicians,
- oxygen saturation above 85% at rest.
Exclusion
- Those with unstable COPD with frequent or acute exacerbations,
- rapidly worsening dyspnea requiring urgent medical intervention,
- treatment with palliative radiotherapy to the chest received within 4 weeks or chemotherapy within 2 weeks;
- experiencing intractable cough, and those having unstable angina or clinically significant pleural effusion needing drainage
Key Trial Info
Start Date :
November 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03834116
Start Date
November 23 2019
End Date
September 15 2021
Last Update
August 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Medical University Hospital
Luzhou, China